NCT04081857View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Health, Subjective
Interventions
DRUG

HGP1810

HGP1810: Vildagliptin/Metformin

DRUG

HCP1704

HCP1704: Vildagliptin/Metformin

Trial Locations (1)

Unknown

Metro hospital, Anyang

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04081857 - A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects | Biotech Hunter | Biotech Hunter